Literature DB >> 19175873

The influence of North American Aboriginal ethnicity on pro-inflammatory and anti-inflammatory cytokine responses to IFN-alpha.

J D Rempel1, K B Aborsangaya, M P Alphonse, G Y Minuk.   

Abstract

North American Aboriginals have an enhanced propensity to clear HCV infection. Interferon (IFN)-alpha is a critical agent in the clearance of hepatitis C virus (HCV) and other viruses; therefore the influence of Aboriginal ethnicity on IFN-alpha responses was investigated in healthy Caucasian population control and Aboriginal cohorts. Cohort peripheral blood mononuclear cells produced similar levels of IFN-alpha upon culture with reovirus, an innocuous virus capable of triggering IFN-alpha synthesis. In addition, similar IFN-gamma synthesis was observed in the presence IFN-alpha or reovirus. In contrast, Caucasian supernatants exhibited greater IL-10 levels (P<0.005), contributing to the overall cytokine balance as assessed by IFN-gamma/IL-10 ratios being consistently elevated in the Aboriginal cohort. The potential of HCV proteins to alter IFN-alpha cytokine induction was also investigated. Although there was some indication that HCV proteins might increase IFN-alpha induced IL-10 synthesis in Caucasians and conversely, IFN-gamma synthesis in Aboriginals, the addition of HCV proteins did not influence IFN-gamma/IL-10 ratios. Finally, signal transducer and activator of transcription (STAT) 3 nuclear translocation was examined by western blot because it is a required intermediate in IFN-alpha induced IL-10 synthesis. Supporting the differential IL-10 production, IFN-alpha and core synergistically enhanced STAT3 nuclear translocation in Caucasian (P<0.05); whereas, nuclear translocation of STAT3 remained unchanged in Aboriginal cells. Taken together, these findings suggest that ethnicity may influence certain responses to IFN-alpha, possibly even in the presence of viral agents. These differences could impact early immune events allowing for enhanced viral clearance in Aboriginal populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175873     DOI: 10.1111/j.1365-2893.2008.01063.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

1.  The potential influence of KIR cluster profiles on disease patterns of Canadian Aboriginals and other indigenous peoples of the Americas.

Authors:  Julia D Rempel; Kim Hawkins; Erin Lande; Peter Nickerson
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

2.  The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine.

Authors:  Ethan Rubinstein; Gerald Predy; Laura Sauvé; Greg W Hammond; Fred Aoki; Chris Sikora; Yan Li; Barbara Law; Scott Halperin; David Scheifele
Journal:  CMAJ       Date:  2011-07-25       Impact factor: 8.262

3.  Circulating and inducible IL-32α in chronic hepatitis C virus infection.

Authors:  Mark Collister; Julia Rempel; Jiaqi Yang; Kelly Kaita; Zach Raizman; Yuwen Gong; Gerald Minuk
Journal:  Can Liver J       Date:  2019-02-25

4.  Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study.

Authors:  Gerald Y Minuk; Meaghan O'Brien; Kim Hawkins; Didi Emokpare; James McHattie; Paul Harris; Lawrence Worobetz; Karen Doucette; Kelly Kaita; Stephen Wong; Gilles Pinette; Julia Uhanova
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

5.  Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.

Authors:  Nasheed Moqueet; Claire Infante-Rivard; Robert W Platt; Jim Young; Curtis Cooper; Mark Hull; Sharon Walmsley; Marina B Klein
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

6.  The Influence of Hepatitis C Viral Loads on Natural Killer Cell Function.

Authors:  Mark Collister; Cindy Ellison; Qian Li; Gerald Y Minuk; Julia D Rempel; Sam K Kung
Journal:  Gastroenterology Res       Date:  2019-02-26

7.  Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients.

Authors:  Julia Uhanova; Gerald Minuk; Federico Lopez Ficher; Natasha Chandok
Journal:  Can J Gastroenterol Hepatol       Date:  2016-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.